+1,839.6%
QBTS vs EMR
+62.0%
+1,777.7%
-71.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +6.6% | -0.4% | +7.0% | +7.1% |
| 7D | +6.8% | +3.1% | +3.8% | +3.2% |
| 30D | -14.9% | -3.5% | -11.3% | -11.8% |
| 3M | -31.6% | +9.8% | -41.4% | -38.9% |
| 6M | -4.9% | +10.8% | -15.7% | -15.1% |
| YTD | -32.4% | +15.9% | -48.4% | -42.0% |
| 1Y | +14.6% | +16.4% | -1.8% | -1.4% |
| 3Y | +1,839.6% | +62.1% | +1,777.5% | +1,078.6% |
| All | +1,839.6% | +62.0% | +1,777.7% | +1,078.6% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling